New York City—June 28, 2010
“Public health data indicate that the prevalence, impact, and economic consequences of osteoarthritis are expected to rise dramatically within the next several decades. Clearly, understanding and preventing this disease is an urgent research challenge,” said
Steven Goldring, M.D., chief scientific officer at Hospital for Special Surgery and co-director of the conference. Timothy Wright, Ph.D., Kirby Chair of Orthopedic Biomechanics at HSS, is also a co-director of the event.
Hospital for Special Surgery is at the forefront of the national movement focused on elevating awareness of OA as well as the research, patient care, and innovation necessary to improve the outcomes in patients suffering from osteoarthritis.
Osteoarthritis (OA) is one of the most urgent health care challenges of our time, affecting 27 million Americans.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics for 14 years in a row and No. 2 in rheumatology by U.S.News & World Report (2023-2024). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In addition, HSS opened a new facility in Florida in early 2020. In 2019, HSS provided care to 151,000 patients and performed more than 35,000 surgical procedures, and people from all 50 U.S. states and 89 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 translational research laboratories, 33 scientists, 10 clinician-scientists, 55 clinical investigators and 245 scientific support staff that drive the HSS research enterprise in the musculoskeletal “ecosystem,” neurology, pain management and rheumatic diseases. The HSS Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is the world’s leading provider of education on musculoskeletal health, with its online learning platform offering more than 300 courses to more than 30,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.
212.606.1197
mediarelations@hss.edu